郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies.

期刊:Journal of controlled release : official journal of the Controlled Release Society发表年份:2019作者:K Varini; P Lécorché; R Sonnette; F Gassiot; B Broc; M Godard; M David; A Faucon; K Abouzid; G Ferracci; J Temsamani; M Khrestchatisky; G Jacquot

药效评价Enzyme-free release of adhered cells from standard culture dishes using intermittent ultrasonic traveling waves.

期刊:Communications biology发表年份:2019作者:Yuta Kurashina; Chikahiro Imashiro; Makoto Hirano; Taiki Kuribara; Kiichiro Totani; Kiyoshi Ohnuma; James Friend; Kenjiro Takemura

药效评价SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization.

期刊:Behavioural pharmacology发表年份:2019作者:Ramakrishna Nirogi; Renny Abraham; Vijay Benade; Rajesh B Medapati; Pradeep Jayarajan; Gopinadh Bhyrapuneni; NageswaraRao Muddana; Venkat R Mekala; Ramkumar Subramanian; Anil Shinde; Ramasastry Kambhampati; Venkat Jasti

药效评价COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia.

期刊:Leukemia发表年份:2019作者:Kristina Klupsch; Vanessa Baeriswyl; Roland Scholz; Joana Dannenberg; Roger Santimaria; David Senn; Elena Kage; Adrian Zumsteg; Isabella Attinger-Toller; Ulrike von der Bey; Susann König-Friedrich; Fanny Dupuy; Wibke Lembke; Clara Albani; Severin Wen